Work

49439 Effect of Ruxolitinib Cream on Patient-Reported Outcomes (PROs) in Children Aged 2–<12 Years With Atopic Dermatitis (AD): Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 3 Study (TRuE-AD3)

Year: 2024

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2024.07.758

Authors: Eric L. Simpson, Lawrence F. Eichenfield, Amy S. Paller, Andrea L. Zaenglein, Joel Schlessinger, Julie S. Shepard, Alim R. Devani, Dareen D. Siri, Daniel Sturm, Qian Li, April W. Armstrong

Institutions: Oregon Health & Science University, University of California San Diego, Northwestern University, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Ohio Pediatric Research Association, Incyte (United States), University of California, Los Angeles

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402104191

FWCI:

Cites:

Cited by:

Related to: 10